EUVIMEDDescubrir EUVIMED
Open access · CC BY 4.0

Neuroprotection From Intracerebral Hemorrhage Following Pharmacological Inhibition of GSK3β Depends on HFE Gene Status

Timothy B Helmuth iD, Kondaiah Palsa, Aurosman Pappus Sahu, Elizabeth B Neely, Rashmi Kumari, Becky Slagle-Webb, Scott D Simon, James R Connor

Journal of Neurochemistry · 2026-03 · 170 (3)

DOI: 10.1111/jnc.70393 ↗

At a glance

Journal article in Journal of Neurochemistry, published online on 2026-03-02. Written by Timothy B Helmuth and 7 co-authors. Institution: Department of Neurosurgery, Penn State College of Medicine, Hershey, Pennsylvania, USA. Major MEDLINE topics: Glycogen Synthase Kinase 3 beta, Cerebral Hemorrhage, Maleimides, Indoles. Cited 1 times so far (Crossref); 33 references. The full text is freely available (open access, CC BY 4.0). Funded by: NIGMS NIH HHS, Penn State College of Medicine.

ResumenSubjectsDatos bibliográficosCiteRelated studies

Abstract (original language)

Iron release from hemoglobin breakdown following an intracerebral hemorrhage (ICH) is a key mediator in stroke‐induced cytotoxicity. We have previously demonstrated that mice carrying the H67D mutation in the homeostatic iron regulatory gene (HFE) experience marked neuroprotection following ICH. This improvement is likely due to an endogenous upregulation in the Nrf2 antioxidant system. Prior studies in H67D mice discovered decreased activity in GSK3β, a kinase that functions to break down Nrf2. Interestingly, pharmacological inhibition of GSK3β has been shown to vastly improve outcomes in ICH animal models. However, it remains unclear whether this pathway is responsible for the enhanced antioxidant response in H67D animals. In this study, H67D and WT mice received daily injections of intraperitoneal SB216763, a selective inhibitor of GSK3β, 14 days prior to ICH. The functional motor recovery of each animal was assessed by rotarod and neurodegeneration was measured using Fluorojade‐B. Immunoblotting assessed the antioxidant response and GSK3β activity through Nrf2, GPX4, FTH1, and β‐Catenin. At 3 days post‐ICH, SB216763‐treated WT mice display enhanced functional recovery, decreased degenerated neurons, and increased brain levels of Nrf2 and GPX4 compared to WT‐Vehicle‐Controls. Further, SB216763 treatment in H67D mice did not result in any significant changes in measured outcomes compared to H67D‐Vehicle‐Controls. In conclusion, WT mice benefit from GSK3β inhibition following ICH whereas H67D animals do not. This suggests that the regulation of the antioxidant response may have reached its biological limit in H67D animals. Importantly, these data suggest that clinical trials aimed towards improving ICH outcomes, especially through GSK3β inhibition, must take into account HFE genotype as this mutation, present in nearly 20% of individuals worldwide, may alter ICH recovery regardless of therapy. image

Subjects

MeSH terms (MEDLINE)

Glycogen Synthase Kinase 3 betaCerebral HemorrhageMaleimidesIndolesNeuroprotective AgentsHemochromatosis ProteinNeuroprotectionAnimalsMiceMaleMice, Inbred C57BL

Author keywords

HFEantioxidantsintracerebral hemorrhageiron

Substances

Glycogen Synthase Kinase 3 betaMaleimidesIndolesNeuroprotective AgentsHemochromatosis ProteinSB 216763Gsk3b protein, mouse

Authors and institutions

  • Department of Neurosurgery, Penn State College of Medicine, Hershey, Pennsylvania, USA.
  • Department of Neural and Behavioral Sciences, Penn State College of Medicine, Hershey, Pennsylvania, USA.

ORCID profiles: Timothy B Helmuth

Funding

  • NIGMS NIH HHS
  • Penn State College of Medicine

Cite

APA

Helmuth, T. B., Palsa, K., Sahu, A. P., Neely, E. B., Kumari, R., Slagle-Webb, B., Simon, S. D., & Connor, J. R. (2026). Neuroprotection From Intracerebral Hemorrhage Following Pharmacological Inhibition of GSK3β Depends on HFE Gene Status. Journal of Neurochemistry, 170(3). https://doi.org/10.1111/jnc.70393

Vancouver

Helmuth TB, Palsa K, Sahu AP, Neely EB, Kumari R, Slagle-Webb B, et al. Neuroprotection From Intracerebral Hemorrhage Following Pharmacological Inhibition of GSK3β Depends on HFE Gene Status. Journal of Neurochemistry. 2026;170(3). doi:10.1111/jnc.70393

BibTeX
@article{Helmuth2026,
  author = {Helmuth, Timothy B and Palsa, Kondaiah and Sahu, Aurosman Pappus and Neely, Elizabeth B and Kumari, Rashmi and Slagle-Webb, Becky and Simon, Scott D and Connor, James R},
  title = {Neuroprotection From Intracerebral Hemorrhage Following Pharmacological Inhibition of GSK3β Depends on HFE Gene Status},
  journal = {Journal of Neurochemistry},
  year = {2026},
  volume = {170},
  number = {3},
  doi = {10.1111/jnc.70393}
}
Start for free →